FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/11/047691 [Registered on: 25/11/2022] Trial Registered Prospectively
Last Modified On: 24/11/2022
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   IN VITRO 
Study Design  Other 
Public Title of Study   To check the effect of Chlorhexidine, Povidone Iodine and Cetyl Pyridinium Chloride containing mouthwashes in removal of microorganisms on dental implant component. 
Scientific Title of Study   Comparative Evaluation of Efficacy of Chlorhexidine, Povidone Iodine and Cetyl Pyridinium Chloride for Decontamination of Healing Abutments: An Invitro Study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR SHRUTI KALBAGE 
Designation  POST GRADUATE STUDENT 
Affiliation  MGM DENTAL COLLEGE AND HOSPITAL 
Address  DEPARTMENT OF PERIODONTICS, MGM DENTAL COLLEGE AND HOSPITAL, SECTOR-1, KAMOTHE

Raigarh
MAHARASHTRA
410209
India 
Phone  09987029607  
Fax  27423185  
Email  kalbageshruti1996@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SARIKA SHETTY 
Designation  READER 
Affiliation  MGM DENTAL COLLEGE AND HOSPITAL 
Address  DEPARTMENT OF PERIODONTICS, MGM DENTAL COLLEGE AND HOSPITAL, SECTOR-1, KAMOTHE

Raigarh
MAHARASHTRA
410209
India 
Phone  9820007410  
Fax  27423185  
Email  shettysarika98@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SHRUTI KALBAGE 
Designation  POST GRADUATE STUDENT 
Affiliation  MGM DENTAL COLLEGE AND HOSPITAL 
Address  DEPARTMENT OF PERIODONTICS, MGM DENTAL COLLEGE AND HOSPITAL, SECTOR-1, KAMOTHE

Raigarh
MAHARASHTRA
410209
India 
Phone  09987029607  
Fax  27423185  
Email  kalbageshruti1996@gmail.com  
 
Source of Monetary or Material Support  
MGM DENTAL COLLEGE AND HOSPITAL, KAMOTHE NAVIMUMBAI 
 
Primary Sponsor  
Name  DR SHRUTI KALBAGE 
Address  DEPARTMENT OF PERIODONTICS, ROOM NO-9, 7th FLOOR, MGM DENTAL COLLEGE AND HOSPITAL, SECTOR-1, KAMOTHE, NAVI MUMBAI 
Type of Sponsor  Other [PRIVATE DENTAL COLLEGE AND HOSPITAL ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SARIKA SHETTY   MGM DENTAL COLLEGE AND HOSPITAL  Department of Periodontics, 7th floor, room no-9, MGM DENTAL COLLEGE AND HOSPITAL, SECTOR-1, KAMOTHE, NAVI MUMBAI
Raigarh
MAHARASHTRA 
09987029607
27423185
shettysarika98@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUITIONAL ETHICS COMMITTEE MAHATMA GANDHI MISSIONS DENTAL COLLEGE AND HOSPITAL KAMOTHE NAVIMUMBAI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B999||Unspecified infectious disease,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  The used healing abutments will be subjected to staining followed by culture method.  The used healing abutments will be subjected to staining method followed by culture methods for evaluation of its contamination. 
Comparator Agent  used healing abutments with positive turbidity will be cleaned and treated with Cetyl Pyridinium chloride 0.05%.  used healing abutments with positive turbidity will be cleaned and treated with Cetyl Pyridinium chloride 0.05%. 
Comparator Agent  used healing abutments with positive turbidity will be cleaned and treated with Chlorhexidine 0.2%  used healing abutments with positive turbidity will be cleaned and treated with Chlorhexidine 0.2% 
Comparator Agent  used healing abutments with positive turbidity will be cleaned and treated with Povidone Iodine 1%.  used healing abutments with positive turbidity will be cleaned and treated with Povidone Iodine 1%. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  The samples collected from the centers should be used within a period of 4 weeks.
The samples collected from the centers that use autoclaving for sterilization.

 
 
ExclusionCriteria 
Details  The sample sterilized pouches those will be perforated will not be included in the study.
ï‚·Healing abutments sterilized by any other method other than autoclaving. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Decontamination of used healing abutments when treated with chlorhexidine, povidone iodine and cetyl pyridinium chloride, Chlorhexidine might be more efficacious than povidone iodine and cetyl pyridinium chloride.  The Healing abutments will be collected over a stipulated period of 1month time frame.  
 
Secondary Outcome  
Outcome  TimePoints 
NONE  NONE 
 
Target Sample Size   Total Sample Size="96"
Sample Size from India="96" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/12/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NONE 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is a prospective in vitro study in which the efficacy of chlorhexidine, povidone iodine and cetyl pyridinium will be evaluated. Healing abutments will be collected from different centers using convenient sampling meeting the inclusion criteria.   These healing abutments will be tested for the turbidity until 96 contaminated healing abutments are obtained, which will be divided into 3 equal groups for their decontamination which will be allocated randomly by onsite computer randomization method. And a total of 32 new healing abutments serving as a control group will be taken from various manufacturers as each manufacturing company has different designs and size of healing abutments.

This study will follow a 3step experimental procedure

Procedure-

In the 1st step- A total of 10 new unused HAs and 24 used HA will be stained using phloxine B stain and photographs will be taken.  And then divided into 3 equal groups Group 1-chlorhexidine 0.2%; Group 2-povidone iodine 1% solutions Group 3-cetyl pyridinium chloride0.05% for sterilization. The staining will be performed by isolating each HAs into a plastic bag containing 2ml of phloxine B and the plastic bag will be placed in an ultra-sonic bath for 15 minutes. After which the HAs will be washed in de ionized water and then air dried. These dried HAs will be observed in oblique light and photographs (Canon 1500D, lens-100mm macro lens) zoomed in their main body, thread and screw holes will be taken. The photographs will be projected on to the computer with 15X magnification and the unused HAs will serve as controls.

In the 2nd step- 22 new HAs with the remaining used HAs present in the sterilized pouches as collected from different centers will be inserted into a sterile test tube holding 10ml of BHI which is a growth media for fastidious microorganisms. An additional test tube containing 10ml of BHI will be set up to serve as a control. All the test tubes will be cultured for 10 days at 37o C in 5% CO2 milleu. These test tube then will be checked for turbidity to assess the presence of microbial colonies. The test tubes that will show turbidity from them inoculum will be obtained and added into the petri dishes containing BHI and PDA. PDA is a general-purpose medium used for yeasts and molds. The petri dishes with inoculum will be cultured at 30oC for 5 days and the process will be repeated several times until the pure culture bacterial colonies are obtained. These colonies of bacteria will be stored in nutrient agar butt at -20o C. The bacterial colonies then obtainedwill be subjected to gram stain and biochemical tests, mainly the catalase test and growth in alkaline medium (PH: 9.2) to establish the characteristics and identity of the of the cultured colonies in order to identify the bacteria rapidly further microbial analysis will be done by using VITEK 2. The fungal growth if obtained in the petri dishes will be subjected to multiple cultures for 7 days at 30oC until the pure cultures are obtained. The identification of the fungus will be done based on the morphology, reverse appearance and coloration. These colorations of the colonies will be assessed in three medias- PDA, malt extract agar and capeks solution.

In the 3rd step- all the contaminated abutments obtained from cultures and 24 used HAs obtained from staining procedure will be divided into three equal groups and cleaned with Group 1-chlorhexidine 0.2%; Group 2-povidone iodine 1% solutions Group 3-cetyl pyridinium chloride0.05%. This will be done by placing the healing abutments in the plastic lock seal bags containing the 10ml of each solution and incubated in the ultrasonic bath for 15mins and subsequent steam autoclaving. The abutments will be extracted and incubated for 10days again in the petri dishes using same procedure as mentioned above. These cultures will be assessed for turbidity, bacterial colonies and molds using microbial analysis. Then the SEM examination will be done to observe the body, threads and screw holes of used HAs after the treatment with respective solutions.

Data Analysis plan and Method-

 

Data collected will be compiled on to a MS Office excel worksheet & will be subjected to statistical analysis using an appropriate package like SPSS software. Descriptive statistics like frequency (n) & percentage (%) ofcategorical data, mean & Standard deviation of numerical data in each group / subgroup will be depicted.

Frequency (n) & percentage (%) of various categories in each group / subgroup will be compared using chi square test.

Normality of numerical data will be checked using Shapiro – Wilk test or Kolmogorov-Smirnov test. Depending on the normality of data, statistical tests will be determined.  

For a numerical continuous data following a normal distribution, inter group comparison (>2 groups) will be done using one way ANOVA test, else a non-parametric substitute like Kruskal Wallis ANOVA test will be used.Intra group comparisons for a numerical continuous data following a normal distribution will be done using paired t test (for 2 observations) or repeated measures ANOVA for >2 observations, else a non-parametric substitute like Wilcoxon signed rank test (for 2 observations) or Friedman’s test for >2 observations will be used. Frequency (n) & percentage (%) of various responses in each time interval will be compared using chi square test / Mc Nemar’s test.

Keeping alpha error at 5% and Beta error at 20%, power at 80%, p<0.05 will be considered statistically significant. 

 
Close